Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
Prime Minister Kevin Rudd has pledged half a billion dollars for Australia's automotive manufacturing industry in an attempt to give investment certainty to local car makers and shore up their future beyond 2020. Under the 'New Car Plan ...
Tags: Auto, Transportation
The Irish Medicines Board and the Netherlands' Medicines Evaluations Board have granted national phase approvals to Apricus Biosciences' Vitaros, indicated to treat patients with erectile dysfunction (ED). Vitaros now has four national ...
Tags: Apricus Bio, Medicine
Northwestern's Bluhm Cardiovascular Institute has recently enrolled first patient in ABSORB III, a clinical trial to compare the performance of Abbott's drug eluting Absorb Bioresorbable Vascular Scaffold (BVS) device with other traditional ...
Tags: Absorb device, Medicine
Abbott Vietnam has expanded the recall of its Similac GainPlus Eye-Q products to include another 4,387 cans of infant formula over concerns of whey concentrate contamination with Clostridium botulinum. The products implicated in the ...
Tags: Abbott, Baby Formula
Australia’s peak national motoring organisation says the Federal Government’s $200 million assistance package for the local car industry is an admission that its changes to the fringe benefits tax (FBT) rules were a mistake. ...
Tags: Package Announcement
China has fined six baby milk formula companies a total of 670 million yuan (US$108 million) for price-fixing, following an anti-trust investigation launched in early July, the country's top economic planner announced Wednesday morning. ...
Tags: Milk Formula, Price-Fixing
China has levied a record fine of US$109 million (RMB668 million) on six baby formula producers as part of an anti-competition probe, South China Morning Post reported. The six companies under fire were Biostime, Mead Johnson, Abbott, ...
Tags: Baby Formula
China has levied a record fine of US$109 million (RMB668 million) on six baby formula producers as part of an anti-competition probe, South China Morning Post reported. The six companies under fire were Biostime, Mead Johnson, Abbott, ...
Tags: Argentine Corn
The Australasian Railway Association has questioned the Coalition Opposition’s intentions with Infrastructure Australia’s funding allocation policies if they were to win government. In presenting their plans for infrastructure ...
Tags: Rail Sector, Rail Projects
IntelligentMDx has secured clearance from the US Food and Drug Administration (FDA) for IMDx VanR for Abbott m2000 assay, an automated molecular diagnostic test that detects the presence of vanA and vanB genes associated with ...
Abbott has obtained approval from US Food and Drug Administration (FDA) for its inpatient blood glucose monitoring system, called FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, which provides test results in real ...
Tags: Abbott, Monitoring System
The infant formula industry is in the spotlight again after the launch of a price-fixing investigation into foreign and domestic milk powder makers and intensified government efforts to consolidate a nationwide hodgepodge of producers. ...
Tags: Dairy Industry, infant formula
Federal opposition leader Tony Abbott says the Coalition does not support the Labor Government’s changes to fringe benefits tax (FBT) rules and will not proceed with the policy changes if elected. The government has attracted ...
US-based Abbott has agreed to buy a stent maker and an eye surgery systems manufacturer in two separate deals, worth about $710m, as part of its strategy to expand its medical device business. Illinois-based Abbott agreed to purchase ...
Tags: Stent Maker, Ophthalmic Device